Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 21 for “"Cytoreduction"”.
-
A population-level evaluation of barriers and facilitators to referral in Cytoreduction/Hyperthermic Intraperitoneal Chemotherapy using knowledge translation methodology.
Introduction: Referral for CS/HIPEC is variable, and barriers encountered by referring physicians are unknown. Identification of such barriers is useful for the creation of tailored knowledge translation (KT) strategies. Methods: Interviews of 20 medical oncologists and surgeons in the New York …
-
Οι επιπτώσεις της κυτταρομειωτικής χειρουργικής και της υπερθέρμου διεγχειρητικής ενδοπεριτοναϊκής χημειοθεραπείας στον πηκτικό μηχανισμό και στην επισκληρίδιο αναισθησία-αναλγησία
… offered significant survival benefit undergoing cytoreduction in combination with hyperthermic intraperitoneal intraoperative chemotherapy (HIPEC). Cytoreductive surgery is associated with coagulopathy alterations. Epidural analgesia is effective in major surgery. The purpose of the study is the …
-
BRCA1/2 mutation spectrum and its prognostic significance for progression-free and overall survival in advanced ovarian cancer /
… most frequent. It amounted to 63.6%. Non-optimal cytoreduction (p<0,0001 ) , patients’ older age (p=0,005) and absence of BRCA1/2 mutations (p=0,049) are closely connected with a shorter PFS and OS. Only non-optimal cytoreduction was related to a shorter OS (p=0,010).
-
Išplitusio kiaušidžių vėžio BRCA1/2 genų mutacijų įvairovė ir jų prognozinė reikšmė ligos berecidyviam ir bendrajam pacienčių išgyvenamumui /
… most frequent. It amounted to 63.6%. Non-optimal cytoreduction (p<0,0001 ) , patients’ older age (p=0,005) and absence of BRCA1/2 mutations (p=0,049) are closely connected with a shorter PFS and OS. Only non-optimal cytoreduction was related to a shorter OS (p=0,010).
-
Effects of the implantation of intra-abdominal protheses in a mouse model of ovarian peritoneal carcinosis
… mesh implantation following resection and/or cytoreduction. Using the murine model of ovarian-type peritoneal cancer (PC) which is induced by intraperitoneal injection of ID8 – Luc ovarian cancer cells in immunocompetent C57BL/6 mice in the presence or the absence of intraabdominal prostheses …
-
Η επίδραση της ενδοπεριτοναϊκής έγχυσης της ρεγοραφενίμπης στην περιτοναϊκή διασπορά του καρκίνου του παχέος εντέρου μετά κυτταρομείωση σε επίμυες
… with a very poor prognosis and quality of life. Cytoreduction combined with intraperitoneal chemotherapy is the most effective treatment strategy in selected patients with resectable colorectal cancer and peritoneal dissemination. Regorafenib is an orally administered, pleiotropic, …
-
Role of the operative tumor reduction in patients with epithelial ovarian cancer and suboptimal tumor debulking
… to gynaecologic cancer worldwide. Surgical cytoreduction is the cornerstone of current treatment in patients with advanced primary disease. In contrast, the value of surgery in recurrent ovarian cancer (ROC) remains unclear. In the present study, we evaluate the role of postoperative tumor …
-
Ο ρόλος των βλαστοκυττάρων στα Γλοιώματα
… όσον αφορά στη μείωση του όγκου των γλοιωμάτων (cytoreduction), αλλά και στη χορήγηση φαρμάκων. Ευτυχώς, η εξέλιξη της τεχνολογίας και της μοριακής βιολογίας δίνει την δυνατότητα στους ερευνητές να εξηγήσουν τα πρώτα βήματα σχηματισμού των γλοιωμάτων και να συγκεντρώσουν γνώσεις σχετικά με τα …
-
Effects of bromelain and N-acetylcysteine on mucin-expressing human gastrointestinal carcinoma cells and their peritoneal spread: towards development of novel locoregional approaches to peritoneal surface malignancies and pathological mucin synthesis
… formulation capable of enhancing microscopic cytoreduction and eliminating mucin. To this end, I investigated growth-inhibitory and mucin-depleting effects of bromelain (BR) and N-acetylcysteine (NAC), two natural agents with good safety profile, in experimental models of gastrointestinal …
-
The psychological impact and clinical outcomes associated with testing for ovarian cancer in symptomatic women
… (performance status, stage at diagnosis, cytoreduction rate, extent of disease) in women diagnosed with high grade serous OC, the most lethal form of OC was evaluated. Results: Findings from our SR demonstrated that the contribution of some factors to anxiety in cancer testing and their …
-
Novel cell intrinsic factors in the pathogenesis of JAK2 V617F positive myeloproliferative neoplasms
… effectively managed by antiplatelet therapy and cytoreduction for selected patients at highest risk. Prognosis is hugely variable and is dependent on multiple factors including disease phenotype, driver mutation status, the presence of additional pathogenic mutations, epigenetic dysregulation and …
-
Elucidation of a novel mechanism of peritoneal dissemination and platinum resistance of ovarian cancer by tumor-associated fibrosis (TAF) 〜Cancer, Fibrosis and Women's Health Care〜
… of peritoneal-specific relapse despite complete cytoreduction. A separate analysis of normal human ovaries indicated an agedependent increase in stromal fibrosis, suggesting a biological continuum between aging and tumor-favorable stromal changes. In summary, our findings identify TAF as a key …
-
Ergebnisse der zytoreduktiven Chirurgie und hyperthermen intraperitonealen Chemotherapie in der Behandlung des peritoneal metastasierten Magenkarzinoms
… Tumorlast wurde über den Completeness of Cytoreduction Score (CC-Score) ermittelt. Die Klassifikation der postoperativen Mortalität erfolgte nach Clavien-Dindo und die Schätzung der Überlebenszeiten nach Kaplan-Meier. Die statistische Aufarbeitung des Datensatzes erfolgte mit IBM …
-
Analysis of essential thrombocythemia and its treatment
… Common treatment approaches seek to use cytoreduction and platelet inhibition to lower the risk of a thrombotic event. Hydroxyurea and low-dose aspirin have been the gold-standard of treatment for ET patients. This thesis sought to compare the current available therapy with second-line …
-
Η χειρουργική αντιμετώπιση του ψευδομυξώματος του περιτοναίου
… περιτοναικής κοιλότητας. Το CCS (completeness of cytoreduction score) είναι το τελικό εργαλείο της διεγχειρητικής αξιολόγησης της πρόγνωσης με βάση την πληρότητα της κυτταρομείωσης. Η σχετιζόμενη με την τεχνική, νοσηρότητα είναι σοβαρή, ειδικά στην περίπτωση εκτεταμένων εξαιρέσεων. Ο κίνδυνος …
-
Is there a place for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the treatment of pancreatic adenocarcinoma? A systematic review.
… A terms: “CRS” OR “cytoreductive surgery” OR “cytoreduction” OR “Hipec” OR “Hyperthermic Intraperitoneal Chemotherapy”. Group B terms: “pancreas” OR “pancreatic”. Χρησιμοποιήθηκαν επιπλέον φίλτρα για τον περιορισμό σε εργασίες που αφορούσαν ανθρώπους, ήταν στην Αγγλική γλώσσα και είχαν …
-
Determining the effect of double-stranded RNA treatment in ovarian cancer
… Standard treatment protocol involves surgical cytoreduction, followed by a combination of taxane and platinum-based chemotherapeutics. Initially this treatment is successful however, most patients face recurring tumors that over time become resistant to current drug regimens. Thus, novel …
-
Μελέτη υποπληθυσμών των λεμφοκυττάρων των όγκων σε καρκίνο ωοθηκών: συσχέτιση με την παραγωγή κυτταροκινών και διερεύνηση της προγνωστικής τους σημασίας
… III and IV). Current treatment includes surgical cytoreduction and post-surgery platinum–paclitaxel chemotherapy. Despite the initial response to treatment, relapse (and death from the disease) will still occur in 70% of patients. Established prognostic factors for EOC include stage, volume of …
-
Immunhistochemische Untersuchungen zur Expression von Tumormarkern und Wachstumsfaktorrezeptoren bei Hunden mit malignen Nasentumoren
Einleitung: Nasenhöhlentumoren stellen mit bis zu 47 % die Hauptursache für Nasenausfluss beim Hund dar. Sie sind überwiegend maligne, zu 60 % Karzinome und zu 34 % Sarkome. Die mediane Überlebenszeit (MÜZ) liegt ohne Therapie bei etwa drei Monaten. Nach einer Bestrahlungstherapie beträgt sie etwa …
-
CT-gesteuerte Hochdosis-Brachytherapie (CT-HDRBT): Ergebnisse der Therapie von Lebertumoren innerhalb und jenseits der Indikationen der Radiofrequenzablation (RFA)
… nach CT-HDRBT im Sinne einer minimal- invasiven Cytoreduction bei 37 Patientinnen mit 80 nicht resektablen BCLM untersucht. Das durchschnittliche Follow-up nach CT-HDRBT betrug 11,6 Monate. Eine lokale Tumorprogression konnte lediglich in zwei (2,6%) der behandelten Metastasen festgestellt …
Page 1 of 2